RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Inari Medical Stock

Inari Medical Net Income 2024

Inari Medical Net Income

-44.54 M USD

Ticker

NARI

ISIN

US45332Y1091

WKN

A2P41U

In 2024, Inari Medical's profit amounted to -44.54 M USD, a 2,622.24% increase from the -1.64 M USD profit recorded in the previous year.

The Inari Medical Net Income history

YEARNET INCOME (undefined USD)
2028e-
2027e53.74
2026e30.81
2025e8.36
2024e-44.54
2023-1.64
2022-29.3
20219.8
202013.8
2019-1.2
2018-10.2

Inari Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Inari Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Inari Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Inari Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Inari Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Inari Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Inari Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Inari Medical’s growth potential.

Inari Medical Revenue, EBIT and net profit per share

DateInari Medical RevenueInari Medical EBITInari Medical Net Income
2028e944.52 M undefined0 undefined0 undefined
2027e1.01 B undefined60.38 M undefined53.74 M undefined
2026e852.17 M undefined34.73 M undefined30.81 M undefined
2025e727.44 M undefined4.06 M undefined8.36 M undefined
2024e615.04 M undefined-30.17 M undefined-44.54 M undefined
2023493.63 M undefined-3.63 M undefined-1.64 M undefined
2022383.5 M undefined-28.1 M undefined-29.3 M undefined
2021277 M undefined10.8 M undefined9.8 M undefined
2020139.7 M undefined18.7 M undefined13.8 M undefined
201951.1 M undefined900,000 undefined-1.2 M undefined
20186.8 M undefined-9.1 M undefined-10.2 M undefined

Inari Medical stock margins

The Inari Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inari Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inari Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Inari Medical's sales revenue. A higher gross margin percentage indicates that the Inari Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Inari Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Inari Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Inari Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Inari Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Inari Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Inari Medical Margin History

Inari Medical Gross marginInari Medical Profit marginInari Medical EBIT marginInari Medical Profit margin
2028e88.03 %0 %0 %
2027e88.03 %6 %5.34 %
2026e88.03 %4.08 %3.62 %
2025e88.03 %0.56 %1.15 %
2024e88.03 %-4.91 %-7.24 %
202388.03 %-0.74 %-0.33 %
202288.4 %-7.33 %-7.64 %
202191.05 %3.9 %3.54 %
202090.69 %13.39 %9.88 %
201988.65 %1.76 %-2.35 %
201880.88 %-133.82 %-150 %

Inari Medical Aktienanalyse

What does Inari Medical do?

Inari Medical Inc. is an American medical technology company founded in 2013 and headquartered in Irvine, California. The company specializes in the development and manufacturing of medical devices for the treatment of vascular diseases. The founders of Inari Medical are Vinayak "Vin" P. Kasabwala and Dr. Thomas "Thom" C. Fogarty. Dr. Fogarty is a well-known pioneer in the field of minimally invasive surgery and has filed more than 160 patents. Both founders have an impressive track record in the development and marketing of medical technology products. Inari Medical's business model is based on the development and marketing of products for the minimally invasive treatment of vascular diseases. The company's goal is to develop medical devices that improve the treatment of these diseases and allow patients to recover faster. Inari Medical is divided into various business units, each specializing in the treatment of different types of vascular diseases. The "VENA" business unit focuses on the treatment of vein diseases such as deep vein thrombosis or blockages of larger veins. The "TROMBUS" business unit is dedicated to the treatment of blood clots in the veins that can be life-threatening. Inari Medical's portfolio includes various medical devices that can be used for this purpose. These include catheters that use ultrasound waves to destroy blood clots without damaging the surrounding tissue. The "PULMUS" business unit specializes in the treatment of pulmonary embolisms, which are blockages of the lung arteries caused by a blood clot. Pulmonary embolisms can be life-threatening and require immediate treatment. Inari Medical Inc. has various products on the market that can be used for the treatment of vascular diseases. These include the ClotTriever thrombectomy catheter, the ClotTriever system, and the FlowTriever system. These products enable fast and effective treatment of vein diseases, blood clots, and pulmonary embolisms. The ClotTriever system is a specially designed catheter that removes compact blood clots that form in the veins and large blood vessels. A special filter system is used to prevent the blood clot from entering other parts of the body. The FlowTriever system, on the other hand, is used for the treatment of pulmonary embolisms. A special catheter is inserted into the pulmonary artery to remove the blood clot and restore blood flow to the lungs. The FlowTriever system is designed to quickly and effectively remove the blood clot without damaging the surrounding tissue. Inari Medical aims to revolutionize the treatment of vascular diseases and enable patients to recover faster. The company has an impressive track record in the development and marketing of medical devices and will continue to offer innovative solutions for the treatment of vascular diseases in the future. Inari Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Inari Medical's Profit Margins

The profit margins of Inari Medical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Inari Medical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Inari Medical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Inari Medical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Inari Medical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Inari Medical stock

How much profit has Inari Medical made this year?

Inari Medical has made -44.54 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 2,622.24% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Inari Medical publish its earnings?

Inari Medical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Inari Medical?

The profits of Inari Medical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Inari Medical?

You can learn more about the earnings of Inari Medical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Inari Medical pay?

Over the past 12 months, Inari Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inari Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Inari Medical?

The current dividend yield of Inari Medical is .

When does Inari Medical pay dividends?

Inari Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inari Medical?

Inari Medical paid dividends every year for the past 0 years.

What is the dividend of Inari Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inari Medical located?

Inari Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inari Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inari Medical from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Inari Medical pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Inari Medical in the year 2023?

In the year 2023, Inari Medical distributed 0 USD as dividends.

In which currency does Inari Medical pay out the dividend?

The dividends of Inari Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Inari Medical

Our stock analysis for Inari Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inari Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.